The global Biomarkers Market was valued at USD 27.91 billion in 2016 and is projected to reach USD 88.99 billion by 2025, growing at a CAGR of 13.75% from 2017 to 2025.
Biomarkers are of immense importance in biotech based research and genetic studies. With Increasing fund and interest of private and public players, the market is expected to grow at a high rate during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Diagnostic applications such as personalized medicine and companion diagnostics
1.2 Increasing funds for R&D
1.3 Increasing Number of Cros and Low Cost of Clinical Trials in Developing Countries
1.4 Increase in the number of cancer cases
1.5 Interests in Biomarker Research
2. Market Restraints
2.1 High Capital Investments and Low Cost-Benefit Ratio
2.2 Poorly Suited Regulatory and Reimbursement Systems
2.3 Technical Issues Related to Sample Collection and Storage
Market Segmentation:
1. Global BiomarkersMarket, by Disease Indication:
1.1 Cancer
1.2 Cardiovascular Disorders
1.3 Neurological Disorders
1.4 Immunological Disorders
1.5 Other Diseases
2. Global BiomarkersMarket, by Application:
2.1 Diagnostics
2.2 Drug Discovery and Development
2.3 Personalized Medicine
2.4 Disease Risk Assessment
2.5 Other Applications
3. Global Biomarkers Market, by Type:
3.1 Safety Biomarkers
3.2 Efficacy Biomarkers
3.2.1 Predictive Biomarkers
3.2.2 Surrogate Biomarkers
3.2.3 Pharmacodynamic Biomarkers
3.2.4 Prognostic Biomarkers
3.3 Validation Biomarkers
4. Global Biomarkers Market, by Product:
4.1 Consumables
4.2 Services
4.3 Software
5. Global Biomarkers Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Qiagen N.V.
2. Perkinelmer, Inc.
3. Merck Millipore
4. Bio-Rad Laboratories, Inc.
5. Enzo Biochem, Inc.
6. EKF Diagnostics Holdings, Inc.
7. Meso Scale Diagnostics, LLC.
8. Biosims Technologies Sas
9. Cisbio Bioassays
10. Signosis, Inc
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the BiomarkersMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL BIOMARKERS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL BIOMARKERSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL BIOMARKERS MARKET, BY DISEASE INDICATION
5.1 Cancer
5.2 Cardiovascular Disorders
5.3 Neurological Disorders
5.4 Immunological Disorders
5.5 Other Diseases
6 GLOBAL BIOMARKERS MARKET, BY APPLICATION
6.1 Diagnostics
6.2 Drug Discovery and Development
6.3 Personalized Medicine
6.4 Disease Risk Assessment
6.5 Other Applications
7 GLOBAL BIOMARKERS MARKET, BY TYPE
7.1 Safety Biomarkers
7.2 Efficacy Biomarkers
7.2.1 Predictive Biomarkers
7.2.2 Surrogate Biomarkers
7.2.3 Pharmacodynamic Biomarkers
7.2.4 Prognostic Biomarkers
7.3 Validation Biomarkers
8 GLOBAL BIOMARKERS MARKET, BY PRODUCT
8.1 Consumables
8.2 Services
8.3 Software
9 GLOBAL BIOMARKERSMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL BIOMARKERSMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Qiagen N.V.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Perkinelmer, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Merck Millipore
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Enzo Biochem, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 EKF Diagnostics Holdings, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Meso Scale Diagnostics, LLC.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Biosims Technologies Sas
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Cisbio Bioassays
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Signosis, Inc
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports
The global Genomic Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this f...
The global Antibiotic Stewardship Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pl...
The global Medical Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this f...
The global Central Nervous System Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pl...
The global Sepsis Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fi...
The global Genomics Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Commercializing Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...
The global Serum Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fie...
The global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID...
The global Serum Cancer Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in t...